Regulation of Fas ligand-induced apoptosis by TNF

Journal of Immunology

Volumn 167, Issue 6, 2001, Pages 3049-3056

  Elzey, B D ^a   Griffith, T S ^a   Herndon, J M ^a   Barreiro, R ^a   Tschopp, J ^a   Ferguson, T A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE ANTIBODY; FAS LIGAND; FLICE INHIBITORY PROTEIN; PICRIC ACID; PROTEIN BAX; PROTEIN P75; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL DEATH; EYE; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0035884803     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.6.3049     Document Type: Article

References (56)

1. Immunologically privileged sites
2. The role of FasL-induced apoptosis in immune privilege
3. Fas ligand-induced apoptosis as a mechanism of immune privilege
4. CD95-induced apoptosis of lymphocytes in an immune privileged site induced immunological tolerance
5. Anti-inflammatory effects of CD95 ligand (FasL)-induced apoptosis
6. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis
7. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus
8. The Fas death factor
9. Role of Fas-mediated cell death in the regulation of immune responses
10. 2+-independent T cell mediated cytotoxicity
11. Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor immune escape
12. Involvement of the CD95 (Apo-1/Fas) receptor and ligand in liver damage
13. Tumor necrosis factor receptor superfamily members and their ligands
14. Apoptosis signaling by death receptors
15. A novel protein that interacts with the death domain of Fas/Apo-I contains a sequence motif related to the death domain
16. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
17. Apoptosis: Molecular regulation of cell death
18. Mechanisms of CD95 (Apo-1/Fas)-mediated apoptosis
19. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis
20. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis
21. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
22. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis
23. Inhibition of death receptor signals by cellular FLIP
24. CASH, a novel caspase homologue with death effector domains
25. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors
26. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein
27. Requirement for casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development
28. Conversion of membrane-bound fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity
29. The immune response and the eye. II. The nature of T suppressor cell induction in anterior chamber associated immune deviation
30. The immune response and the eye. III. Anterior chamber associated immune deviation can be adoptively transferred by serum
31. Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: Identification of a novel in vivo role for p75
32. The immune response and the eye. IV. A role for tumor necrosis factor in anterior chamber associated immune deviation
33. Membrane tumor necrosis factor (TNF) induced cooperative signaling of TNFR60 and TNFR80 favors induction of cell death rather than virus production in HIV-infected T cells
34. Cooperation of both TNF receptors in inducing apoptosis: Involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75
35. Induction of apoptosis in mature T cells by tumour necrosis factor
36. BCL-2 family: Regulators of cell death
37. Bcl-2 heterodimerizes in vivo with a conserved homolog. Bax, that accelerates programmed cell death
38. L and Bcl-2, displaces Bax and promotes cell death
39. Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions
40. The two different receptors for tumor necrosis factor mediate distinct cellular responses
41. Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses
42. Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-κB: TNFα is not needed for induction of a biological effect via TNF receptors
43. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies
44. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity
45. Ligand passing: The 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor
46. TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways
47. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80
48. Enhancement of Ag and mitogen induced human T lymphocyte proliferation by tumor necrosis factor-α
49. TNF receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1
50. TNF receptor 2 deficient CD8 T cells are resistant to Fas/FasL-induced death
51. Signaling by the TNF receptor superfamily and T cell homeostasis
52. Soluble TNF receptor production by activated T lymphocytes: Differential effects of acute and chronic exposure to TNF
53. Bcl-2 and Bax function independently to regulate cell death
54. Regulation of the proinflammatory effects of Fas ligand (CD95L)
55. A vision of cell death: Insights into immune privilege
56. Neuropeptides modulate immune deviation induced via the anterior chamber of the eye